Keywords: procysteine, trial, ards, suspended, transcend, therapeutics, its

Procysteine Trial In ARDS Suspended

Article | 26 March 1998

Transcend Therapeutics has suspended its Phase III trial of intravenousprocysteine, a glutathione-depleting agent, in patients with acute respiratory distress syndrome, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Nystatin

Go to drug listing